Back to RecallTracker
Health Canada Health products

Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals

Issued May 13, 2004
Issue
Hazard description
Product safety